Excessive ranges of autoimmune antibodies are noticed in COVID-19 sufferers however their particular contribution to illness severity and medical manifestations stays poorly understood. We carried out a retrospective research of 115 COVID-19 hospitalized sufferers with totally different levels of severity to research the technology of autoimmune antibodies to frequent antigens: a lysate of erythrocytes, the lipid phosphatidylserine (PS) and DNA.
Excessive ranges of IgG autoantibodies towards erythrocyte lysates have been noticed in a big proportion (as much as 36%) of sufferers. Anti-DNA and anti-PS antibodies decided upon hospital admission correlated strongly with later growth of extreme illness, exhibiting a constructive predictive worth of 85.7% and 92.8%, respectively. Sufferers with constructive values for not less than one of many two autoantibodies accounted for 24% of complete extreme instances.
Statistical evaluation recognized robust correlations between anti-DNA antibodies and markers of cell damage, coagulation, neutrophil ranges and erythrocyte dimension. Anti-DNA and anti-PS autoantibodies might play an essential position within the pathogenesis of COVID-19 and could possibly be developed as predictive biomarkers for illness severity and particular medical manifestations.
Anti-TRBC1 Antibody-Based mostly Circulate Cytometric Detection of T-Cell Clonality: Standardization of Pattern Preparation and Diagnostic Implementation
A single antibody (anti-TRBC1; JOVI-1 antibody clone) towards one of many two mutually unique T-cell receptor β-chain fixed domains was recognized as a probably helpful flow-cytometry (FCM) marker to evaluate Tαβ-cell clonality. We optimized the TRBC1-FCM method for detecting clonal Tαβ-cells and validated the tactic in 211 regular, reactive and pathological samples.
TRBC1 labeling considerably improved within the presence of CD3. Purified TRBC1+ and TRBC1– monoclonal and polyclonal Tαβ-cells rearranged TRBJ1 in 44/47 (94%) and TRBJ1+TRBJ2 in 48 of 48 (100%) populations, respectively, which confirmed the excessive specificity of this assay.
Moreover, TRBC1+/TRBC1– ratios inside totally different Tαβ-cell subsets are supplied as reference for polyclonal cells, amongst which a bimodal sample of TRBC1-expression profile was discovered for all TCRVβ households, whereas highly-variable TRBC1+/TRBC1– ratios have been noticed in additional mature vs. naïve Tαβ-cell subsets (vs. complete T-cells). In 112/117 (96%) samples containing clonal Tαβ-cells through which the method was validated, monotypic expression of TRBC1 was confirmed.
Dilutional experiments confirmed a stage of detection for detecting clonal Tαβ-cells of ≤10-4 in seven out of eight pathological samples. These outcomes help implementation of the optimized TRBC1-FCM method as a quick, particular and correct technique for assessing T-cell clonality in diagnostic-FCM panels, and for minimal (residual) illness detection in mature Tαβ+ leukemia/lymphoma sufferers.
IgG antibodies reacting with ghrelin and leptin are correlated with physique composition and appetitive traits in younger topics
Appetitive traits are essential behavioural traits affecting consuming and physique composition. Ghrelin and leptin are two key hormones regulating urge for food and metabolism. Current research have reported the presence of autoantibodies (autoAbs) directed to ghrelin and leptin in wholesome people in addition to affinity alterations in consuming problems resembling anorexia nervosa and hyperphagic weight problems. Nonetheless, the connection of those autoAbs with appetitive traits is unknown.
The targets of this exploratory research have been to research circulating IgG autoAbs reacting to ghrelin and leptin and consider their relationship with physique composition parameters and appetitive traits. This cross-sectional research included 180 younger topics (20 ± 2 years) that underwent physique composition analysis. Seven appetitive traits have been assessed with AEBQ-Esp and have been categorized as low-score or high-score.
A validated in-house ELISA take a look at was carried out to measure IgG ghrelin and leptin-reactive autoAbs in its free, complete, and immune complexes fractions. Free IgG ghrelin-reactive have been considerably greater in ladies than in males. Immune complexes of IgG-ghrelin have been positively correlated with waist-hip ratio within the complete cohort.
In ladies, free IgG leptin-reactive have been positively correlated with physique fats proportion and waist-hip ratio, whereas in males, immune complexes of IgG-leptin have been positively correlated with physique fats proportion.
Ladies with a low-score for ‘enjoyment of meals’, exhibited greater ranges of IgG ghrelin-reactive autoAbs on its free kind than the high-score group. Males with a high-score for ’emotional undereating’ had greater ranges of free IgG leptin-reactive autoAbs than the low-score group.
The correlation of those autoAbs with anthropometric parameters and appetitive traits in younger topics help its position as carriers and modulators of the biologic features of ghrelin and leptin and counsel a novel position in consuming behaviour by means of appetitive traits.
Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
The result of the latest Antibody Mediated Prevention (AMP) trials that examined infusion of the broadly neutralizing antibody (bnAb) VRC01 offers proof of idea for blocking an infection from delicate HIV-1 strains. These outcomes additionally open up the chance that triple mixtures of bnAbs resembling PGT121, PGDM1400, in addition to long-lasting LS variants resembling VRC07-523 LS, have immunoprophylactic potential.
PGT121 and PGDM1400 goal the HIV-1 V3 and V2 glycan areas of the gp120 envelope protein, respectively, whereas VRC07-523LS targets the HIV-1 CD4 binding website. These bnAbs show neutralization efficiency and complementary breadth of HIV-1 pressure protection.
An essential medical trial final result is the correct measurement of in vivo concentrations of passively infused bnAbs to find out efficient doses for remedy and/or prevention. Standardization and validation of this testing technique is a key ingredient for medical research as is the power to concurrently detect a number of bnAbs in a selected method.
Right here we report the event of a delicate, particular, correct, and exact multiplexed microsphere-based assay that concurrently quantifies the respective physiological concentrations of passively infused bnAbs in human serum to in the end outline the brink wanted for defense from HIV-1 an infection.
Miniaturized single-cell applied sciences for monoclonal antibody discovery
Antibodies (Abs) are among the many most essential class of biologicals, showcasing a excessive therapeutic and diagnostic worth. Within the world therapeutic Ab market, fully-human monoclonal Abs (FH-mAbs) are flourishing because of their low immunogenicity and excessive specificity.
The quickly rising discipline of single-cell applied sciences has paved the best way to effectively uncover mAbs by facilitating a quick screening of the antigen (Ag)-specificity and performance of Abs expressed by B cells. This evaluation summarizes the rules and challenges of the 4 key ideas to find mAbs utilizing these applied sciences, being confinement of single cells utilizing both droplet microfluidics or microstructure arrays, identification of the cells of curiosity, retrieval of these cells and single-cell sequence willpower required for mAb manufacturing.
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC941130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF594 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC941130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF594 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNCA1130-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), APC conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC811130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC811130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNUB1130-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Concentration: 0.2mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNUB1130-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Concentration: 0.2mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNCH1130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNCH1130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC881130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF488A conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC881130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF488A conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC611130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF660R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC611130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF660R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC681130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF568 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC681130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF568 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC431130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF543 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC431130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF543 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC471130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF647 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC471130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF647 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC401130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF640R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC401130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF640R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC551130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF555 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC551130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF555 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC801130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC801130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF680 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC051130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF405M conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC051130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF405M conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC701130-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF770 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNC701130-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), CF770 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(MUC18/1130) Antibody |
BNUM1130-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(MUC18/1130), 1mg/mL |
Anti-MUC18/ CD146/ MCAM Antibody Clone MUC18/1130, Unconjugated-100ug |
4162-MSM4-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
CD146 Antibody / MCAM / MUC18 |
V8923-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: The human MCAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated Mel-CAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MCAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V8923-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
Description: The human MCAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated Mel-CAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MCAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V8923SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: The human MCAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated Mel-CAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MCAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2696-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2696-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2696IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2696SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MCAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2697-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2697-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2697IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2697SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2698-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2698-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2698IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2698SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human CD146 gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2699-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2699-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2699IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2699SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V3638-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V3638-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V3638IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V3638SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD146 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. It is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7138-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt] |
CD146 Antibody / MCAM / MUC18 |
V7138-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt] |
CD146 Antibody / MCAM / MUC18 |
V7138IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt] |
CD146 Antibody / MCAM / MUC18 |
V7138SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD146/MUC18/MCAM plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration. [UniProt] |
Cd146 Antibody / MCAM / MUC18 |
RQ5987 |
NSJ Bioreagents |
100 ug |
EUR 419 |
Description: In humans, the CD146 protein is encoded by the MCAM gene. It is mapped to 9; 9 A5.1. CD146 (cluster of differentiation 146) also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. MCAM functions as a receptor for laminin alpha 4, a matrix molecule that is broadly expressed within the vascular wall. Accordingly, MCAM is highly expressed by cells that are components of the blood vessel wall, including vascular endothelial cells, smooth muscle cells and pericytes. Its function is still poorly understood, but evidence points to it being part of the endothelial junction associated with the actin cytoskeleton. A member of the Immunoglobulin superfamily, it consists of five Ig domains, a transmembrane domain, and a cytoplasmic region. It is expressed on chicken embryonic spleen and thymus, activated human T cells, endothelial progenitors such as angioblasts and mesenchymal stem cells, and strongly expressed on blood vessel endothelium and smooth muscle. |
CD146 Antibody / MCAM / MUC18 |
V2189-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MUC18 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MUC18 / CD146 is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2189-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MUC18 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MUC18 / CD146 is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V2189SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. MUC18 expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. MUC18 / CD146 is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7942-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7942-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7942SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7943-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7943-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
CD146 Antibody / MCAM / MUC18 |
V7943SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The human Mel-CAM gene maps to chromosome 11q23 and encodes a trans-membrane glycoprotein, also designated MCAM, MUC 18 or CD146, that belongs to the immunoglobulin superfamily and functions as a Ca2+-independent cell adhesion molecule. Mel-CAM expression is restricted to advanced primary and metastatic melanomas and to cell lines of the neuroectodermal lineage, but not normal melanocytes. Mel-CAM is found on 80% of advanced primary human melanomas and correlates well with development of metastatic disease. |
MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MUC18/1130 (Concentrate) |
RA0444-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 150 |
MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MUC18/1130 (Concentrate) |
RA0444-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 360 |
MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MUC18/1130 (Concentrate) |
RA0444-C1 |
ScyTek Laboratories |
1 ml |
EUR 600 |
Monoclonal MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) Antibody, Clone: MUC18/1130 |
AMM01013G |
Leading Biology |
7 ml |
EUR 580.8 |
Description: A Monoclonal antibody against Human MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule). The antibodies are raised in Mouse and are from clone MUC18/1130. This antibody is applicable in IHC, IF, FC |
Cell surface glycoprotein MUC18 Antibody |
20-abx109638 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cell surface glycoprotein MUC18 Polyclonal Antibody |
42523-100ul |
SAB |
100ul |
EUR 399.6 |
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx139732-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
Cell surface glycoprotein MUC18 Antibody (Biotin) |
20-abx105251 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cell surface glycoprotein MUC18 Antibody (HRP) |
20-abx108086 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cell surface glycoprotein MUC18 Antibody (FITC) |
20-abx106669 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx019043-100ug |
Abbexa |
100 ug |
EUR 410.4 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx200495-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
20-abx225287 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 376.80
|
|
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx413746-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx413749-25ug |
Abbexa |
25 ug |
EUR 326.4 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx413750-1mg |
Abbexa |
1 mg |
EUR 994.8 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx231428-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody |
abx231429-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC040676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405S conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC040676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405S conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC050676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405M conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC050676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF405M conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCAP0676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCAP0676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCB0676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Biotin conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCB0676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Biotin conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCP0676-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), PerCP conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCR0676-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), RPE conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC940676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF594 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC940676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF594 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCA0676-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), APC conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC810676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC810676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNUB0676-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Concentration: 0.2mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNUB0676-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Concentration: 0.2mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCH0676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNCH0676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC880676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF488A conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC880676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF488A conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC680676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF568 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC680676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF568 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC470676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF647 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC470676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF647 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC400676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF640R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC400676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF640R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC430676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF543 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC430676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF543 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC550676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF555 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC550676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF555 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC610676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF660R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC610676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF660R conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC800676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC800676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF680 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC700676-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF770 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNC700676-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), CF770 conjugate, Concentration: 0.1mg/mL |
MUC18 / Mucin 18 / CD146(OJ79c) Antibody |
BNUM0676-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against MUC18 / Mucin 18 / CD146(OJ79c), 1mg/mL |
Human Cell surface glycoprotein MUC18 (MCAM) |
1-CSB-RP104394h |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Cell surface glycoprotein MUC18(MCAM),partial expressed in E.coli |
Monoclonal MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) Antibody - With BSA and Azide, Clone: MUC18/1130 |
AMM01014G |
Leading Biology |
0.05mg |
EUR 475.2 |
Description: A Monoclonal antibody against Human MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) - With BSA and Azide. The antibodies are raised in Mouse and are from clone MUC18/1130. This antibody is applicable in IHC, IF, FC |
Monoclonal MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) Antibody - Without BSA and Azide, Clone: MUC18/1130 |
AMM01015G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone MUC18/1130. This antibody is applicable in IHC, IF, FC |
Cell Surface Glycoprotein MUC18 (CD146) Antibody (PE) |
abx139733-100tests |
Abbexa |
100 tests |
EUR 577.2 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody (PE) |
abx200497-100tests |
Abbexa |
100 tests |
EUR 543.6 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody (APC) |
abx200498-100tests |
Abbexa |
100 tests |
EUR 543.6 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody (PerCP) |
abx200499-100tests |
Abbexa |
100 tests |
EUR 543.6 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody (FITC) |
abx413747-01mg |
Abbexa |
0.1 mg |
EUR 693.6 |
|
Cell Surface Glycoprotein MUC18 (CD146) Antibody (FITC) |
abx413748-25ug |
Abbexa |
25 ug |
EUR 360 |
|
Cell surface glycoprotein MUC18 Polyclonal Conjugated Antibody |
C42523 |
SAB |
100ul |
EUR 476.4 |
Anti-Cell Surface Glycoprotein MUC18 Antibody BIOTIN |
STJ501820 |
St John's Laboratory |
100 µg |
EUR 703.2 |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC040634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF405S conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC040634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF405S conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC041101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF405S conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC041101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF405S conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC050634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF405M conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC050634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF405M conjugate, Concentration: 0.1mg/mL |
Mouse Cell surface glycoprotein MUC18(MCAM) ELISA kit |
CSB-EL013563MO-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Cell surface glycoprotein MUC18 (MCAM) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Mouse Cell surface glycoprotein MUC18(MCAM) ELISA kit |
1-CSB-EL013563MO |
Cusabio |
-
EUR 964.80
-
EUR 6118.80
-
EUR 3244.80
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Cell surface glycoprotein MUC18(MCAM) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCAP0634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCAP0634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCAP1101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCAP1101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCB0634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Biotin conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCB0634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Biotin conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCB1101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Biotin conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCB1101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Biotin conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCP0634-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), PerCP conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCP1101-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), PerCP conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCR0634-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), RPE conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCR1101-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), RPE conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC940634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF594 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC940634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF594 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC941101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF594 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC941101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF594 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCA0634-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), APC conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCA1101-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), APC conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC810634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF680R conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC810634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF680R conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC811101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF680R conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC811101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF680R conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNUB0634-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Concentration: 0.2mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNUB0634-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Concentration: 0.2mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNUB1101-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Concentration: 0.2mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNUB1101-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Concentration: 0.2mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCH0634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNCH0634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCH1101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNCH1101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC880634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF488A conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC880634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF488A conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC881101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF488A conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC881101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF488A conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC611101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF660R conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC611101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF660R conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC680634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF568 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC680634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF568 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC681101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF568 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC681101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF568 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC431101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF543 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC431101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF543 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC470634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF647 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC470634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF647 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC471101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF647 conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC471101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF647 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC400634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF640R conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC400634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF640R conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC401101-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF640R conjugate, Concentration: 0.1mg/mL |
MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101) Antibody |
BNC401101-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MCAM / MUC18 / Mucin 18 / CD146(MCAM/1101), CF640R conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC430634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF543 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC430634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF543 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC550634-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF555 conjugate, Concentration: 0.1mg/mL |
CD146 / MCAM / MUC18 / Mucin 18(C146/634) Antibody |
BNC550634-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD146 / MCAM / MUC18 / Mucin 18(C146/634), CF555 conjugate, Concentration: 0.1mg/mL |
This evaluation reveals the big potential for mix-and-matching of the above-mentioned methods, which is illustrated by the plethora of established, extremely built-in gadgets. Lastly, an outlook is given on the various alternatives and challenges that also lie forward to totally exploit miniaturized single-cell applied sciences for mAb discovery.